Dr. Andrew Craig on $25 million gift from Cara and Murray Sinclair – Queen’s Health Sciences
Bishal Gyawali shared a post by Queen’s Health Sciences on X/Twitter:
“Amazing news for us at The Sinclair Cancer Research Institute, Queen’s Health Sciences. Thank you to the donors for recognizing the important work being done here.”
Quoting Queen’s Health Sciences’s post:
” ‘This has the potential to dramatically improve outcomes for patients with cancer.’ Dr. Andrew Craig, Director of The Sinclair Cancer Research Institute on a transformative $25 million gift from Cara and Murray Sinclair that will advance cancer research and training.”
Further information.
Source: Bishal Gyawali/X and Queen’s Health Sciences/X
Bishal Gyawali, MD, PhD, is a medical oncologist from Nepal. Currently an Associate Professor at Queen’s University, Kingston, Canada, and affiliated with Brigham and Women’s Hospital, Boston, USA, he is involved in global oncology initiatives. Dr. Gyawali serves on several committees, including the WHO Essential Medicines List Cancer Medicines Working Group and ASCO’s Health Equity and Outcomes Committee, contributing significantly to cancer policy and evidence-based oncology.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023